CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden

Peng Liu1, Yen-Rei A Yu, Jessica A Spencer

  • 1Thurston Arthritis Research Center and Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7280, USA.

Insights

Dendritic cells (DCs) accumulate in arteries, promoting atherosclerosis. The chemokine receptor CX3CR1 is crucial for DC accumulation and reduces atherosclerosis severity in mice.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Atherosclerosis Research

Background:

  • Dendritic cells (DCs) are implicated in atherosclerosis development.
  • The chemokine receptor CX3CR1 is linked to arterial injury and atherosclerosis.

Purpose of the Study:

  • To investigate the relationship between arterial DC accumulation, CX3CR1, and atherosclerosis.
  • To determine if CX3CR1 influences DC presence in atherosclerotic arteries.

Main Methods:

  • Mouse aortas were analyzed using en face immunofluorescence.
  • DC distribution and numbers were quantified in wild-type (WT) and CX3CR1-deficient mice, including ApoE-/- models.

Main Results:

  • DCs predominantly localized to intimal regions of arterial branch points and curvatures.
  • Intimal DC accumulation increased in aged and ApoE-/- aortas, correlating with higher atherosclerosis incidence.
  • CX3CR1 deficiency significantly reduced DC numbers in the aortic wall and decreased atherosclerotic burden.

Conclusions:

  • Intimal DC accumulation is a key factor in the pathogenesis of atherosclerosis.
  • CX3CR1 plays a critical role in mediating DC recruitment to the aorta.
  • Targeting CX3CR1 may offer a therapeutic strategy to reduce atherosclerosis.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...